What is Tfr therapy? Understanding Treatment-Free Remission and Transferrin Receptor Targeting
•
4 min read
Clinical studies show that around 50% of eligible chronic myeloid leukemia (CML) patients can successfully achieve Treatment-Free Remission (TFR) after stopping tyrosine kinase inhibitor (TKI) therapy. This outcome demonstrates a growing push toward reducing lifelong medication dependence in oncology.
